Levofloxacin, Bismuth, Amoxicillin and Esomeprazole As Second-Line Helicobacter pylori Therapy After Failure of Non-Bismuth Quadruple Therapy

被引:0
|
作者
Song, Zhiqiang
Zhou, Liya
机构
关键词
D O I
10.1016/S0016-5085(16)32965-1
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Tu1340
引用
收藏
页码:S879 / S879
页数:1
相关论文
共 50 条
  • [21] Non-bismuth quadruple therapy for first-line Helicobacter pylori eradication:A randomized study in Japan
    Ayako Yanai
    Kei Sakamoto
    Masao Akanuma
    Keiji Ogura
    Shin Maeda
    World Journal of Gastrointestinal Pharmacology and Therapeutics, 2012, (01) : 1 - 6
  • [22] Bismuth containing quadruple therapy for second line Helicobacter pylori eradication
    Lee, M.
    Lee, B.
    Kim, G.
    Park, E.
    Jeon, H.
    Song, G.
    HELICOBACTER, 2017, 22
  • [23] Levofloxacin/amoxicillin-based schemes vs quadruple therapy for Helicobacter pylori eradication in second-line
    Simona Di Caro
    Lucia Fini
    Yayha Daoud
    Fabio Grizzi
    Antonio Gasbarrini
    Antonino De Lorenzo
    Laura Di Renzo
    Sara McCartney
    Stuart Bloom
    World Journal of Gastroenterology, 2012, 18 (40) : 5669 - 5678
  • [24] Levofloxacin/amoxicillin-based schemes vs quadruple therapy for Helicobacter pylori eradication in second-line
    Di Caro, Simona
    Fini, Lucia
    Daoud, Yayha
    Grizzi, Fabio
    Gasbarrini, Antonio
    De Lorenzo, Antonino
    Di Renzo, Laura
    McCartney, Sara
    Bloom, Stuart
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (40) : 5669 - 5678
  • [25] Sequential versus concomitant non-bismuth quadruple therapy as first-line eradication for helicobacter pylori
    Pereira, F.
    Azevedo, R.
    Linhares, M.
    Ramos, D.
    Pinto, J.
    Caldeira, A.
    Tristan, J.
    Pereira, E.
    Sousa, R.
    Banhudo, A.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2019, 31
  • [26] Second-line bismuth-containing quadruple therapy for Helicobacter pylori eradication and impact of diabetes
    Kim, Sung Eun
    Park, Moo In
    Park, Seun Ja
    Moon, Won
    Kim, Jae Hyun
    Jung, Kyoungwon
    Kim, Hae Koo
    Dal Lee, Young
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (06) : 1059 - 1066
  • [27] Second-line bismuth-containing quadruple therapy for Helicobacter pylori eradication and impact of diabetes
    Sung Eun Kim
    Moo In Park
    Seun Ja Park
    Won Moon
    Jae Hyun Kim
    Kyoungwon Jung
    Hae Koo Kim
    Young Dal Lee
    World Journal of Gastroenterology, 2017, (06) : 1059 - 1066
  • [28] Efficacy of Twice a Day Bismuth Quadruple Therapy for Second-Line Treatment of Helicobacter pylori Infection
    Kim, Jeemyoung
    Gong, Eun Jeong
    Seo, Myeongsook
    Seo, Hyun Il
    Park, Jong Kyu
    Lee, Sang Jin
    Han, Koon Hee
    Jeong, Woo Jin
    Kim, Young Don
    Cheon, Gab Jin
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (01):
  • [29] Efficacy of 10-day bismuth quadruple therapy and 14-day quadruple therapy for second-line Helicobacter pylori therapy
    Jung, Jae-Kwon
    Kim, Hyun-Soo
    Park, Chang-Keun
    Kim, Dae-Jin
    Chung, Yun-Jin
    Lee, Jae-Kwang
    Ryu, Hanjun
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 355 - 355
  • [30] Levofloxacin-Containing Sequential Therapy May Not Be Better than Levofloxacin Triple Therapy after Failure of Non-Bismuth Quadruple Therapies
    Kim, Joon Sung
    Kim, Byung-Wook
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 (10): : 1497 - 1497